1,598
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study

, , , , ORCID Icon &
Pages 646-652 | Received 29 Jan 2019, Accepted 30 May 2019, Published online: 15 Jul 2019

References

  • Cannata-Andía JB, Fernández-Martín JL, Zoccali C, et al. Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS). J Nephrol. 2008;21:290–298.
  • He Q, Zhuang D, Zheng L, et al. Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: a single-center experience. BMC Surg. 2014;14:26.
  • Sarfati E, Drueke TB. Surgical management of secondary hyperparathyroidism. In: Olgaard K, Silver J, Salusky IB, editors. The spectrum of mineral and bone disorders in chronic kidney disease. 2nd ed. Oxford (UK): Oxford University Press; 2010. p. 543–559.
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1–S130.
  • Tublin ME, Yim JH, Carty SE. Recurrent hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings. J Ultrasound Med. 2007;26:847–851.
  • Noussios G, Anagnostis P, Natsis K. Ectopic parathyroid glands and their anatomical, clinical and surgical implications. Exp Clin Endocrinol Diabetes. 2012;120:604–610.
  • Lu HI, Chou FF, Chi SY, et al. Thoracoscopic removal of hypertrophic mediastinal parathyroid glands in recurrent secondary hyperparathyroidism. World J Surg. 2015;39:400–409.
  • Alesina PF, Moka D, Mahlstedt J, et al. Thoracoscopic removal of mediastinal hyperfunctioning parathyroid glands: personal experience and review of the literature. World J Surg. 2008;32:224–231.
  • Ravipati NB, McLemore EC, Schlinkert RT, et al. Anterior mediastinotomy for parathyroidectomy. Am J Surg. 2008;195:799–802.
  • Randone B, Costi R, Scatton O, et al. Thoracoscopic removal of mediastinal parathyroid glands. A critical appraisal of an emerging technique. Ann Surg. 2010;251:717–721.
  • Simental A, Ferris RL. Reoperative parathyroidectomy. Otolaryngol Clin North Am. 2008;41:1269–1274.
  • Yen TW, Wang TS, Doffek KM, et al. Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. Surgery. 2008;144:611–619.
  • Torres PU, Prié D, Beck L, et al. New therapies for uremic secondary hyperparathyroidism. J Ren Nutr. 2006;16:87–99.
  • Dietrich CF, Müller T, Bojunga J, et al. Statement and recommendations on interventional ultrasound as a thyroid diagnostic and treatment procedure. Ultrasound Med Biol. 2018;44:14–36.
  • Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound. 2017;20:11–22.
  • Mauri G, Nicosia L, Della Vigna P, et al. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019;38:25–36.
  • Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39:1023–1030.
  • Solbiati L, Giangrande A, De Pra L, et al. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology. 1985;155:607–610.
  • Xu SY, Wang Y, Xie Q, et al. Percutaneous sonography-guided radiofrequency ablation in the management of parathyroid adenoma. Singapore Med J. 2013;54:e137–e140.
  • Wang R, Jiang T, Chen Z, et al. Regression of calcinosis following treatment with radiofrequency thermoablation for severe secondary hyperparathyroidism in a hemodialysis patient. Intern Med. 2013;52:583–587.
  • Singh Ospina N, Thompson GB, Lee RA, et al. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2015;100:E87–E90.
  • Andrioli M, Riganti F, Pacella CM, et al. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: present and future perspectives. AJR Am J Roentgenol. 2012;199:1164–1168.
  • Kovatcheva RD, Vlahov JD, Stoinov JI, et al. High-intensity focussed ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism. Nephrol Dial Transplant. 2012;27:76–80.
  • Machi J. Radiofrequency ablation for hyperparathyroidism: can it be a new treatment? Surg Laparosc Endosc Percutan Tech. 2006;16:116.
  • Zhuo L, Peng LL, Zhang YM, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease—a pilot study. Radiology. 2017;282:576–584.
  • Yu MA, Yao L, Zhang L, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperthermia. 2016;32:180–186.
  • Juergensen PH, Cooper K, Kliger AS, et al. Hyperparathyroidism: a seven-year follow-up. Adv Perit Dial. 1998;14:188–190.
  • Roy M, Mazeh H, Chen H, et al. Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J Surg. 2013;37:102–106.
  • Kim HS, Choi BH, Park JR, et al. Delayed surgery for parathyroid adenoma misdiagnosed as a thyroid nodule and treated with radiofrequency ablation. Endocrinol Metab. 2013;28:231–235.
  • Yang J, Hao R, Yuan L, et al. Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism. AJR Am J Roentgenol. 2014;202:180–184.
  • Monchik JM, Donatini G, Iannuccilli J, et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006;244:296–304.
  • Sacks D, McClenny TE, Cardella JF, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–S202.
  • Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am. 2009;89:1227–1239.
  • Rajagopalan MS, Narla VV, Kanderi T, et al. Para-hyoid ectopic parathyroid adenoma localized by Tc-99m MIBI SPECT. Clin Nucl Med. 2008;33:880–881.
  • Chen HH, Lin CJ, Wu CJ, et al. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg. 2011;253:786–790.
  • Said SM, Cassivi SD, Allen MS, et al. Minimally invasive resection for mediastinal ectopic parathyroid glands. Ann Thorac Surg. 2013;96:1229–1233.
  • Kim C, Lee JH, Choi YJ, et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur Radiol. 2017;27:3128–3137.
  • Peng C, Zhang Z, Liu J, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck. 2017;39:564–571.
  • Jiang T, Chen F, Zhou X, et al. Percutaneous ultrasound-guided laser ablation with contrast-enhanced ultrasonography for hyperfunctioning parathyroid adenoma: a preliminary case series. Int J Endocrinol. 2015;2015:1.
  • Li X, An C, Yu M, et al. US-guided microwave ablation for secondary hyperparathyroidism in patients after renal transplantation: a pilot study. Int J Hyperthermia. 2019;36:322–327.